121 related articles for article (PubMed ID: 20510610)
1. Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Shi W; Duan Y; Qian Y; Li M; Yang L; Hu W
Bioorg Med Chem Lett; 2010 Jun; 20(12):3592-5. PubMed ID: 20510610
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
[TBL] [Abstract][Full Text] [Related]
4. Peptidomimetic inhibitors of bacterial peptide deformylase.
East SP; Ayscough A; Toogood-Johnson I; Taylor S; Thomas W
Bioorg Med Chem Lett; 2011 Jul; 21(13):4032-5. PubMed ID: 21621999
[TBL] [Abstract][Full Text] [Related]
5. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
6. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antibacterial activity of (2S)-N-(substitutedphenyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxohexyl]-2-pyrrolidinecarboxamides as potential peptide deformylase inhibitors.
Wang Z; Zhou W
Chem Biol Drug Des; 2009 Jan; 73(1):142-6. PubMed ID: 19152643
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives--an extended structure-activity relationship study.
Mahboobi S; Eichhorn E; Winkler M; Sellmer A; Möllmann U
Eur J Med Chem; 2008 Mar; 43(3):633-56. PubMed ID: 17624634
[TBL] [Abstract][Full Text] [Related]
9. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
10. 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
Mahboobi S; Eichhorn E; Popp A; Sellmer A; Elz S; Möllmann U
Eur J Med Chem; 2006 Feb; 41(2):176-91. PubMed ID: 16375991
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
Boularot A; Giglione C; Artaud I; Meinnel T
Curr Opin Investig Drugs; 2004 Aug; 5(8):809-22. PubMed ID: 15600237
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
Grant SK; Green BG; Kozarich JW
Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antibacterial and anticonvulsant evaluations of some cyclic enaminones.
Edafiogho IO; Phillips OA; Udo EE; Samuel S; Rethish B
Eur J Med Chem; 2009 Mar; 44(3):967-75. PubMed ID: 18715680
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of (-)-deoxypseudophrynaminol versus its racemate and derivatives.
Dix AV; Meseck CM; Lowe AJ; Mitchell MO
Bioorg Med Chem Lett; 2006 May; 16(9):2522-4. PubMed ID: 16464587
[TBL] [Abstract][Full Text] [Related]
15. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
Howard MH; Cenizal T; Gutteridge S; Hanna WS; Tao Y; Totrov M; Wittenbach VA; Zheng YJ
J Med Chem; 2004 Dec; 47(27):6669-72. PubMed ID: 15615515
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the design of antibiotics targeting peptide deformylase.
Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
[TBL] [Abstract][Full Text] [Related]
17. Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics.
Naidu BN; Sorenson ME; Zhang Y; Kim OK; Matiskella JD; Wichtowski JA; Connolly TP; Li W; Lam KS; Bronson JJ; Pucci MJ; Clark JM; Ueda Y
Bioorg Med Chem Lett; 2004 Nov; 14(22):5573-7. PubMed ID: 15482927
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological action of 1-aminomethyl derivatives of 3-R-4-phenyl-delta2-1,2,4-triazoline-5-thione.
Pitucha M; Wujec M; Dobosz M; Kosikowska U; Malm A
Acta Pol Pharm; 2005; 62(6):443-9. PubMed ID: 16583983
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors.
Yu L; Zhou W; Wang Z
Bioorg Med Chem Lett; 2011 Mar; 21(5):1541-4. PubMed ID: 21288715
[TBL] [Abstract][Full Text] [Related]
20. Peptide deformylase inhibitors.
Aubart K; Zalacain M
Prog Med Chem; 2006; 44():109-43. PubMed ID: 16697896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
